These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22000605)

  • 1. Achieving translation in models of visceral pain.
    Bulmer DC; Grundy D
    Curr Opin Pharmacol; 2011 Dec; 11(6):575-81. PubMed ID: 22000605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histamine Receptor H1-Mediated Sensitization of TRPV1 Mediates Visceral Hypersensitivity and Symptoms in Patients With Irritable Bowel Syndrome.
    Wouters MM; Balemans D; Van Wanrooy S; Dooley J; Cibert-Goton V; Alpizar YA; Valdez-Morales EE; Nasser Y; Van Veldhoven PP; Vanbrabant W; Van der Merwe S; Mols R; Ghesquière B; Cirillo C; Kortekaas I; Carmeliet P; Peetermans WE; Vermeire S; Rutgeerts P; Augustijns P; Hellings PW; Belmans A; Vanner S; Bulmer DC; Talavera K; Vanden Berghe P; Liston A; Boeckxstaens GE
    Gastroenterology; 2016 Apr; 150(4):875-87.e9. PubMed ID: 26752109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of experimental models in developing new treatments for irritable bowel syndrome.
    Holschneider DP; Bradesi S; Mayer EA
    Expert Rev Gastroenterol Hepatol; 2011 Feb; 5(1):43-57. PubMed ID: 21309671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Placebo effect in patients with irritable bowel syndrome.
    Lu CL; Chang FY
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():116-8. PubMed ID: 21751434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral hypersensitivity in irritable bowel syndrome.
    Kanazawa M; Hongo M; Fukudo S
    J Gastroenterol Hepatol; 2011 Apr; 26 Suppl 3():119-21. PubMed ID: 21443723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRPV1: a new target for treatment of visceral pain in IBS?
    Holzer P
    Gut; 2008 Jul; 57(7):882-4. PubMed ID: 18559382
    [No Abstract]   [Full Text] [Related]  

  • 7. Targeting voltage-gated sodium channels for treatment for chronic visceral pain.
    Qi FH; Zhou YL; Xu GY
    World J Gastroenterol; 2011 May; 17(19):2357-64. PubMed ID: 21633634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New Drugs on the Horizon for Functional and Motility Gastrointestinal Disorders.
    Camilleri M
    Gastroenterology; 2021 Sep; 161(3):761-764. PubMed ID: 33989661
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug discovery approaches to irritable bowel syndrome.
    Hornby PJ
    Expert Opin Drug Discov; 2015; 10(8):809-24. PubMed ID: 26193876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging receptor target in the pharmacotherapy of irritable bowel syndrome with constipation.
    Blackshaw LA; Brierley SM
    Expert Rev Gastroenterol Hepatol; 2013 Jul; 7(5 Suppl 1):15-9. PubMed ID: 23859756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irritable bowel syndrome: focus on otilonium bromide.
    Boeckxstaens G; Clavé P; Corazziari ES; Tack J
    Expert Rev Gastroenterol Hepatol; 2014 Feb; 8(2):131-7. PubMed ID: 24417261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of transient receptor potential vanilloid type-1 (TRPV1) channel as promising therapy of irritable bowel syndrome: characterization of the action of palvanil in the mouse gastrointestinal tract.
    Szymaszkiewicz A; Włodarczyk J; Wasilewski A; Di Marzo V; Storr M; Fichna J; Zielińska M
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Aug; 393(8):1357-1364. PubMed ID: 32002574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantification and Potential Functions of Endogenous Agonists of Transient Receptor Potential Channels in Patients With Irritable Bowel Syndrome.
    Cenac N; Bautzova T; Le Faouder P; Veldhuis NA; Poole DP; Rolland C; Bertrand J; Liedtke W; Dubourdeau M; Bertrand-Michel J; Zecchi L; Stanghellini V; Bunnett NW; Barbara G; Vergnolle N
    Gastroenterology; 2015 Aug; 149(2):433-44.e7. PubMed ID: 25911511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Miltefosine treatment reduces visceral hypersensitivity in a rat model for irritable bowel syndrome via multiple mechanisms.
    Botschuijver S; van Diest SA; van Thiel IAM; Saia RS; Strik AS; Yu Z; Maria-Ferreira D; Welting O; Keszthelyi D; Jennings G; Heinsbroek SEM; Elferink RPO; Schuren FHJ; de Jonge WJ; van den Wijngaard RM
    Sci Rep; 2019 Aug; 9(1):12530. PubMed ID: 31467355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ion channels as drug targets in central nervous system disorders.
    Waszkielewicz AM; Gunia A; Szkaradek N; Słoczyńska K; Krupińska S; Marona H
    Curr Med Chem; 2013; 20(10):1241-85. PubMed ID: 23409712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methyl-orvinol-Dual activity opioid receptor ligand inhibits gastrointestinal transit and alleviates abdominal pain in the mouse models mimicking diarrhea-predominant irritable bowel syndrome.
    Zielińska M; Jarmuż A; Wasilewski A; Cami-Kobeci G; Husbands S; Fichna J
    Pharmacol Rep; 2017 Apr; 69(2):350-357. PubMed ID: 28187396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Visceral analgesics: drugs with a great potential in functional disorders?
    Bradesi S; Herman J; Mayer EA
    Curr Opin Pharmacol; 2008 Dec; 8(6):697-703. PubMed ID: 18786654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review article: transient receptor potential channels as possible therapeutic targets in irritable bowel syndrome.
    Beckers AB; Weerts ZZRM; Helyes Z; Masclee AAM; Keszthelyi D
    Aliment Pharmacol Ther; 2017 Nov; 46(10):938-952. PubMed ID: 28884838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New pharmacological treatment options for irritable bowel syndrome with constipation.
    Nusrat S; Miner PB
    Expert Opin Emerg Drugs; 2015; 20(4):625-36. PubMed ID: 26548544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRP channel functions in the gastrointestinal tract.
    Yu X; Yu M; Liu Y; Yu S
    Semin Immunopathol; 2016 May; 38(3):385-96. PubMed ID: 26459157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.